Literature DB >> 31555686

Clinical characteristics and management of cardiac and/or pulmonary cement embolus after percutaneous vertebroplasty: a single center experience.

Min Kong1,2, Xinjian Xu3,4, Jianfei Shen2, Qiang Liu3, Gongchao Wang1.   

Abstract

BACKGROUND: Cardiac and/or pulmonary cement embolus (CPCE) caused by the leakage of bone cement after percutaneous vertebroplasty (PVP) are rare but are lethal complications in patients with vertebral compression fracture (VCF). Literature in this field is limited, and guidelines for the management of such complications are unclear. This study aimed to review our center's experience.
METHODS: Medical records (clinical characteristics and management) and imaging data (X-ray findings, CT findings, and fluoroscopic findings) of 12 patients with CPCE after PVP between October 2015 and July 2018 at our hospital were collected and examined retrospectively. Their health conditions were also evaluated through a telephone follow-up survey.
RESULTS: Twelve patients with an average age of 76.8±8.5 years were included in our study. One patient who had a cardiac cement embolus and one patient who suffered from an inferior vena cava (IVC) cement embolus were successfully treated via percutaneous retrieval. Ten asymptomatic patients with pulmonary cement embolus (PCE) were managed with conservative observation. All of the patients were alive and remained asymptomatic during the follow-up period (median time, 6.5 months; range, 1-50 months).
CONCLUSIONS: More attention should be paid to the possibility of development of CPCE. For patients with cardiac cement embolus, open heart surgery should be considered as a preferred treatment, and percutaneous procedure could be used as an alternative treatment for patients with surgical contraindication or other surgical high-risk factors. For patients with an IVC cement spike, percutaneous retrieval could be recommended. Careful observation and clinical follow-up could be recommended for patients with asymptomatic peripheral or central PCEs.

Entities:  

Keywords:  Percutaneous vertebroplasty (PVP); bone cement; embolus

Year:  2019        PMID: 31555686      PMCID: PMC6736822          DOI: 10.21037/atm.2019.06.81

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  20 in total

Review 1.  Anatomical and pathological considerations in percutaneous vertebroplasty and kyphoplasty: a reappraisal of the vertebral venous system.

Authors:  Rob J M Groen; Don F du Toit; Frank M Phillips; Piet V J M Hoogland; Karel Kuizenga; Maarten H Coppes; Christo J F Muller; Marie Grobbelaar; Johannes Mattyssen
Journal:  Spine (Phila Pa 1976)       Date:  2004-07-01       Impact factor: 3.468

2.  Images in cardiovascular medicine. Acute pericarditis caused by acrylic bone cement after percutaneous vertebroplasty.

Authors:  Jae-Hyeong Park; Suk Jung Choo; Seong-Wook Park
Journal:  Circulation       Date:  2005-02-15       Impact factor: 29.690

3.  Treatment of painful compression vertebral fractures with vertebroplasty: results and complications.

Authors:  Giovanni Carlo Anselmetti; Andrea Corgnier; Felicino Debernardi; Daniele Regge
Journal:  Radiol Med       Date:  2005-09       Impact factor: 3.469

4.  Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study.

Authors:  B Cortet; A Cotten; N Boutry; R M Flipo; B Duquesnoy; P Chastanet; B Delcambre
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

5.  Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty.

Authors:  Du Hwan Choe; Edith M Marom; Kamran Ahrar; Mylene T Truong; John E Madewell
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

Review 6.  Management of pulmonary cement embolism after percutaneous vertebroplasty and kyphoplasty: a systematic review of the literature.

Authors:  Antonio Krueger; Christopher Bliemel; Ralph Zettl; Steffen Ruchholtz
Journal:  Eur Spine J       Date:  2009-07-04       Impact factor: 3.134

7.  Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro.

Authors:  Ales Blinc; Mojca Bozic; Rok Vengust; Mojca Stegnar
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

Review 8.  Cardiac tamponade and pulmonary embolism as a complication of percutaneous vertebroplasty.

Authors:  Baris Caynak; Burak Onan; Ertan Sagbas; Cihan Duran; Belhhan Akpinar
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

9.  Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty.

Authors:  A Venmans; P N M Lohle; W J van Rooij; H J J Verhaar; W P Th M Mali
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

10.  Pulmonary cement embolism after percutaneous vertebroplasty in osteoporotic vertebral compression fractures: incidence, characteristics, and risk factors.

Authors:  Yeo Ju Kim; Joon Woo Lee; Kun Woo Park; Jin-Seob Yeom; Hee Sun Jeong; Jeong Mi Park; Heung Sik Kang
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

View more
  3 in total

1.  Correlation analysis of the puncture-side bone cement/vertebral body volume ratio and bone cement leakage in the paravertebral vein in vertebroplasty.

Authors:  Tao Gao; Zhi-Yu Chen; Tao Li; Xu Lin; Hai-Gang Hu; De-Chao Yuan; Jun Zeng; Chao Wu
Journal:  BMC Musculoskelet Disord       Date:  2022-02-26       Impact factor: 2.362

2.  Effects of high viscosity bone cement percutaneous vertebroplasty on pain, bone specific alkaline phosphatase, Type-I collage cross-linked-telopeptide and Boneglaprotein levels in patients with osteoporotic vertebral compression fractures.

Authors:  Guangcheng Zhang; Juan Zhu; Qing Zhang; Jiazhu Tang; Mingjun Nie
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

3.  Case report: Cement entrapped in the inferior vena cava filter after pedicle screw augmentation.

Authors:  Xinqiang Han; Yongzhen Zhang; Zhu Wang; Mengpeng Zhao
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.